Impact of neoadjuvant intensity-modulated radiation therapy on borderline resectable pancreatic cancer with arterial abutment; a prospective, open-label, phase II study in a single institution

Table 3 Surgical outcomes and Pathological features

Surgical outcome	NACIMRT (n = 29)
Type of procedure (PD/DP/TP)	24/4/1
Operation time (min)	552 (370–747)
Blood loss (ml)	558 (125–2900)
PV/SMV resection	21(72.4%)
CHA/SMA resection	4 (13.8%)
CR-POPF (grade B or C)	5 (17.2%)
Clavian Dindo IIIa <	4 (13.7%)
re-operation	0
Duration of in-hospital stay	26.5 (15–58)
in-hospital death	0
Alb 1 month after resection (mg/dl)	3.3 (2.3–4.1)
ChE 1 month after resection (U/L)	186 (77–349)
relative dose intensity of adjuvant S1 (%)	75 (0–100)^a
Pathological features
Tumor diameter (mm)	22 (0–55)
R0	27/29 (93.1%)
positive LN metastasis	10 (34.4%)
Evans Grading (1/2a/2b/3/4)	1/9/14/1/1

^anot started in two patients (judged by a doctor)
Abbreviations: PD pancreaticoduodenectomy, DP distal pancreatectomy, TP total pancreatectomy, PV portal vein, SMV superior mesenteric vein, CHA common hepatic artery, SMA superior mesenteric artery, CR-POPF clinically relevant postoperative pancreatic fistula, Alb albumin, ChE cholinesterase, R0 microscopically margin-negative resection, LN lymph node

ISSN: 1471-2407